Fig. 5
From: Integrated genomic characterization of cancer genes in glioma
Correlation of MSH6 and RUNX1T1 expression with patients’ prognosis in glioma. a Patients with high expression of MSH6 (log2 normalized count was above 146.48, red) showed a poor survival rate as compared to glioma patients with low expression of MSH6 (log2 normalized count was smaller than 47.69, blue). b Glioma patients with high expression of RUNX1T1 (log2 normalized count was above 1035.7, red) showed a better prognosis than patients with low expression of RUNX1TX (log2 normalized count was less than 759.39, blue)